The global sulfasalazine tablets market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of inflammatory bowel disease and rheumatoid arthritis globally. The global sulfasalazine tablets market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into 250mg sulfasalazine tablets and 500mg sulfasalazine tablets. On the basis of application, it is segmented into rheumatoid arthritis, ulcerative colitis, Crohn's disease. On the basis of region it includes North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia). - Increasing prevalence of inflammatory bowel disease (IBD) and ulcerative colitis in the US, Europe, and Japan. - Presence of key players in the market such as Salix Pharmaceuticals Inc, Takeda Pharmaceutical Company Limited, AstraZeneca plc, and Pfizer Inc.
Industry Growth Insights published a new data on “Sulfasalazine Tablets Market”. The research report is titled “Sulfasalazine Tablets Market research by Types (250mg Sulfasalazine Tablets, 500mg Sulfasalazine Tablets), By Applications (Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, Other), By Players/Companies Pfizer, Teva Pharmaceuticals, Santen, Watson Labs, Vintage Pharms, Pharmacia and Upjohn, Hubei Wudang, Shanxi Wanshou, Chongqing Dikang, Hebei Yinengpu, Guangzhou Huahai, Fujian Fukang, Kamp Medicine, Hebei Dongfeng, Chengdu No.1 Pharm, Youhua, Hanwang, Jindao”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sulfasalazine Tablets Market Research Report
By Type
250mg Sulfasalazine Tablets, 500mg Sulfasalazine Tablets
By Application
Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, Other
By Companies
Pfizer, Teva Pharmaceuticals, Santen, Watson Labs, Vintage Pharms, Pharmacia and Upjohn, Hubei Wudang, Shanxi Wanshou, Chongqing Dikang, Hebei Yinengpu, Guangzhou Huahai, Fujian Fukang, Kamp Medicine, Hebei Dongfeng, Chengdu No.1 Pharm, Youhua, Hanwang, Jindao
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Sulfasalazine Tablets Market Report Segments:
The global Sulfasalazine Tablets market is segmented on the basis of:
Types
250mg Sulfasalazine Tablets, 500mg Sulfasalazine Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Teva Pharmaceuticals
- Santen
- Watson Labs
- Vintage Pharms
- Pharmacia and Upjohn
- Hubei Wudang
- Shanxi Wanshou
- Chongqing Dikang
- Hebei Yinengpu
- Guangzhou Huahai
- Fujian Fukang
- Kamp Medicine
- Hebei Dongfeng
- Chengdu No.1 Pharm
- Youhua
- Hanwang
- Jindao
Highlights of The Sulfasalazine Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 250mg Sulfasalazine Tablets
- 500mg Sulfasalazine Tablets
- By Application:
- Rheumatoid Arthritis
- Ulcerative Colitis
- Crohn's Disease
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sulfasalazine Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sulfasalazine tablets are a medication used to treat inflammatory bowel disease (IBD). Sulfasalazine is an antibiotic that works by reducing the number of bacteria in the intestines. This can help to relieve symptoms such as diarrhea, constipation, and abdominal pain.
Some of the major players in the sulfasalazine tablets market are Pfizer, Teva Pharmaceuticals, Santen, Watson Labs, Vintage Pharms, Pharmacia and Upjohn, Hubei Wudang, Shanxi Wanshou, Chongqing Dikang, Hebei Yinengpu, Guangzhou Huahai, Fujian Fukang, Kamp Medicine, Hebei Dongfeng, Chengdu No.1 Pharm, Youhua, Hanwang, Jindao.
The sulfasalazine tablets market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sulfasalazine Tablets Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sulfasalazine Tablets Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sulfasalazine Tablets Market - Supply Chain
4.5. Global Sulfasalazine Tablets Market Forecast
4.5.1. Sulfasalazine Tablets Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sulfasalazine Tablets Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sulfasalazine Tablets Market Absolute $ Opportunity
5. Global Sulfasalazine Tablets Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sulfasalazine Tablets Market Size and Volume Forecast by Type
5.3.1. 250mg Sulfasalazine Tablets
5.3.2. 500mg Sulfasalazine Tablets
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sulfasalazine Tablets Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sulfasalazine Tablets Market Size and Volume Forecast by Application
6.3.1. Rheumatoid Arthritis
6.3.2. Ulcerative Colitis
6.3.3. Crohn's Disease
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sulfasalazine Tablets Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sulfasalazine Tablets Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sulfasalazine Tablets Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sulfasalazine Tablets Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sulfasalazine Tablets Demand Share Forecast, 2019-2026
9. North America Sulfasalazine Tablets Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sulfasalazine Tablets Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sulfasalazine Tablets Market Size and Volume Forecast by Application
9.4.1. Rheumatoid Arthritis
9.4.2. Ulcerative Colitis
9.4.3. Crohn's Disease
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sulfasalazine Tablets Market Size and Volume Forecast by Type
9.7.1. 250mg Sulfasalazine Tablets
9.7.2. 500mg Sulfasalazine Tablets
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sulfasalazine Tablets Demand Share Forecast, 2019-2026
10. Latin America Sulfasalazine Tablets Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sulfasalazine Tablets Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sulfasalazine Tablets Market Size and Volume Forecast by Application
10.4.1. Rheumatoid Arthritis
10.4.2. Ulcerative Colitis
10.4.3. Crohn's Disease
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sulfasalazine Tablets Market Size and Volume Forecast by Type
10.7.1. 250mg Sulfasalazine Tablets
10.7.2. 500mg Sulfasalazine Tablets
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sulfasalazine Tablets Demand Share Forecast, 2019-2026
11. Europe Sulfasalazine Tablets Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sulfasalazine Tablets Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sulfasalazine Tablets Market Size and Volume Forecast by Application
11.4.1. Rheumatoid Arthritis
11.4.2. Ulcerative Colitis
11.4.3. Crohn's Disease
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sulfasalazine Tablets Market Size and Volume Forecast by Type
11.7.1. 250mg Sulfasalazine Tablets
11.7.2. 500mg Sulfasalazine Tablets
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sulfasalazine Tablets Demand Share, 2019-2026
12. Asia Pacific Sulfasalazine Tablets Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sulfasalazine Tablets Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sulfasalazine Tablets Market Size and Volume Forecast by Application
12.4.1. Rheumatoid Arthritis
12.4.2. Ulcerative Colitis
12.4.3. Crohn's Disease
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sulfasalazine Tablets Market Size and Volume Forecast by Type
12.7.1. 250mg Sulfasalazine Tablets
12.7.2. 500mg Sulfasalazine Tablets
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sulfasalazine Tablets Demand Share, 2019-2026
13. Middle East & Africa Sulfasalazine Tablets Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sulfasalazine Tablets Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sulfasalazine Tablets Market Size and Volume Forecast by Application
13.4.1. Rheumatoid Arthritis
13.4.2. Ulcerative Colitis
13.4.3. Crohn's Disease
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sulfasalazine Tablets Market Size and Volume Forecast by Type
13.7.1. 250mg Sulfasalazine Tablets
13.7.2. 500mg Sulfasalazine Tablets
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sulfasalazine Tablets Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sulfasalazine Tablets Market: Market Share Analysis
14.2. Sulfasalazine Tablets Distributors and Customers
14.3. Sulfasalazine Tablets Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Santen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Watson Labs
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Vintage Pharms
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pharmacia and Upjohn
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hubei Wudang
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shanxi Wanshou
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Chongqing Dikang
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hebei Yinengpu
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Guangzhou Huahai
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Fujian Fukang
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Kamp Medicine
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Hebei Dongfeng
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Chengdu No.1 Pharm
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Youhua
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Hanwang
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Jindao
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook